MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Total Assets 2011-2026 | ZBH
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.4 B | 21.5 B | 21.1 B | 23.5 B | 24.4 M | 24.6 B | 24.1 B | 26 B | 26.7 B | 27.2 B | 9.63 B | 9.58 B | 9.01 B | 8.52 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.2 B | 24.4 M | 18.1 B |
Quarterly Total Assets Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.5 B | 22.9 B | 22.2 B | 21.7 B | 21.5 B | 21.5 B | 21.2 B | 21.3 B | 21.2 B | 21.1 B | 21.3 B | - | 21.6 B | 23.5 B | 24 B | 24.2 B | 23.5 B | 24.4 B | 24.4 B | 24.4 B | 24.4 B | 24.6 B | 24.6 B | 24.6 B | 24.6 B | 24.1 B | 24.1 B | 24.1 B | 24.1 B | 26 B | 26 B | 26 B | 26 B | 26.7 B | 26.7 B | 26.7 B | 26.7 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 9.66 B | 9.66 B | 9.63 B | 9.63 B | 9.6 B | 9.58 B | 9.58 B | 9.58 B | 9.01 B | 9.01 B | 9.01 B | 9.01 B | 8.52 B | 8.52 B | 8.52 B | 8.52 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.2 B | 8.52 B | 19.9 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sensus Healthcare
SRTS
|
53 M | $ 3.88 | -3.24 % | $ 63.3 M |  USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 26.41 | -1.39 % | $ 604 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.71 | -4.84 % | $ 33.3 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 22.21 | -4.76 % | $ 1.51 B | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.63 | -0.03 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.45 | - | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Viemed Healthcare
VMD
|
199 M | $ 9.16 | -0.65 % | $ 356 M | USA |
 |
Outset Medical
OM
|
264 M | $ 3.43 | -2.7 % | $ 52.2 K | USA |
 |
Vivos Therapeutics
VVOS
|
15.3 M | $ 1.19 | 0.02 % | $ 5.97 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.62 | 3.32 % | $ 33.7 M | USA |
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.23 | -1.76 % | $ 3.48 M | USA |
 |
PAVmed
PAVM
|
33.1 M | $ 8.91 | -0.28 % | $ 64.4 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
69.4 M | $ 1.7 | -1.73 % | $ 109 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.32 | -0.79 % | $ 1.53 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.45 | 1.24 % | $ 6.8 M | USA |
 |
Penumbra
PEN
|
1.83 B | $ 335.61 | -0.24 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.87 | -1.78 % | $ 572 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
16.8 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.66 | -2.85 % | $ 27.6 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 49.09 | -2.7 % | $ 1.44 B | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.21 | -2.82 % | $ 49.2 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
2.22 B | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |